Lung Cancer Research
Cosponsor Lung Cancer Mortality Reduction Act
STS Request to Congress
- Please cosponsor the Lung Cancer Mortality Reduction Act of 2011 (S. 752/H.R. 1394)
The Lung Cancer Mortality Reduction Act of 2011, introduced in the House by Congresswoman Donna Christensen (D-VI) and Congressman Frank LoBiondo (R-NJ), and Senators Diane Feinstein (D-CA), Johnny Isakson (R-GA), and John Kerry (D-MA) in the Senate, would help provide for the early detection of lung cancer - the leading cause of cancer death in the United States.
The legislation would require the Secretary of the Department of Health and Human Services (HHS) to implement a program with the goal of reducing the mortality rate of lung cancer over the course of the next ten years. This goal would be achieved through new research grants leading to improved diagnostic, surgical, treatment, and drug testing innovations. Additionally, the bill requires coordination among the Secretaries of Defense and Veterans Affairs to develop the mortality reduction program with HHS as well as the implementation of new coordinated care programs and an early detection and disease management research program for military personnel and veterans diagnosed with lung cancer.
- One in every three cancer deaths is caused by lung cancer.
- On average, lung cancer ends 437 American lives every day.
- Lung cancer will kill more than three times as many men as prostate cancer and nearly twice as many women as breast cancer.
- Mounting research suggests that the pattern and course of lung cancer differs between women and men, and that genetic, hormonal, behavioral and environmental factors are involved.
- About $9.6 billion is spent in the U.S. each year treating lung cancer, mostly during late stages when survival is highly unlikely.
- Researchers at the National Cancer Institute found that low-dose CT screening of an at-risk population can significantly reduce lung cancer mortality.
Out of the shadows women and lung cancer. (2010, May). Women’s Health Policy and Advocacy Program, Brigham and Women's Hospital and Harvard Medical School, Retrieved from http://www.lungcanceralliance.org/shadows/Out_of_the_Shadows_Report.pdf.
National lung screening trial (nlst) (2010, November). National Cancer Institute, National Institutes of Health, Retrieved from http://www.cancer.gov/clinicaltrials/noteworthy-trials/nlst.